HOME >> MEDICINE >> NEWS
Immunological karma: T cells reactive to old flu infections make unrelated viral infections worse

Childhood infection with Epstein-Barr virus (EBV) is often asymptomatic, while the same infection in adolescents and adults causes infectious mononucleosis (IM). Liisa Selin and colleagues from the University of Massachusetts Medical School now show how, in a strange twist of immunological karma, T cells specific to a previously encountered virus (such as the flu) may come back to haunt you, by overzealously responding to a subsequent, unrelated viral infection like EBV, thereby increasing the severity of the immune response and causing IM. Their results appear online on November 23 in advance of print publication in the December issue of the Journal of Clinical Investigation.

The authors found that, in patients with IM, memory CD8+ T cells specific to an epitope of the influenza virus encountered in a previous infection, also recognized and reacted to an epitope of the Epstein-Barr virus. These two epitopes, with only 33% similarity, stimulate different T cell activities, which in sum skew the immune response to EBV infection. Excessive lymphocyte proliferation contributes to the marked deviation in disease course and is symptomatic of IM.

Overall, this demonstration of cross-reactivity involving 2 immunodominant epitopes from 2 of the most common human viruses highlights the potential importance of cross-reactive T cells in human disease states.


'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
23-Nov-2005


Page: 1

Related medicine news :

1. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
2. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
3. New algorithm matches any tumor cells to best possible anti-cancer treatments
4. Aging stem cells in mice may hold answers to diseases of the aged, Stanford study finds
5. Loss of stem cells correlates with premature aging in animal study
6. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
7. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
8. Stanford researchers track human stem cells transplanted into rat brain
9. Nurse cells make life and death decisions for infection-fighting cells
10. Adult brain cells rediscover their inner child
11. Stem cells provide clues to cancer spread

Post Your Comments:
(Date:5/20/2013)... (HealthDay News) -- Although many hospital intensive care ... to help improve outcomes, new research suggests this ... Since one-third of teaching hospitals in the United ... a nighttime physician in the ICU, the practice ... away from hospitals with fewer resources, the study ...
(Date:5/20/2013)... Serena Gordon HealthDay Reporter , , MONDAY, May ... cough that was phased out in the late 1990s ... vaccine, a new study contends. Teenagers who received ... vaccine -- before they were 2 years old were ... during a recent outbreak in California, compared to children ...
(Date:5/20/2013)... Posterior fossa subdural hematoma (PFSDH) is a serious ... deliveries. But with appropriate treatment, there,s an excellent chance ... PFSDH, reports a study in the May issue of ... Congress of Neurological Surgeons . The journal is ... part of Wolters Kluwer Health . , The ...
(Date:5/20/2013)... toothpaste that transforms the sweet flavor of orange juice ... mysterious sensory phenomenon in colorful, animated detail ... award-winning Bytesize Science video series at ... scientific society, explains that the mainstay ingredients in toothpaste ... for short. When you brush your teeth, SLS produces ...
(Date:5/20/2013)... A new "telerehabilitation" approach lets physical therapists assess patients ... good accuracy compared with face-to-face examinations, reports a study ... . The journal is published by ... Wolters Kluwer Health . , Taking advantage of Skype ... feasible alternative to in-person clinic visits, according to the ...
Breaking Medicine News(10 mins):Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:Study: Older Whooping Cough Vaccine More Effective 2Health News:Study: Older Whooping Cough Vaccine More Effective 3Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:Telerehabilitation allows accurate assessment of patients with low back pain 2Health News:Telerehabilitation allows accurate assessment of patients with low back pain 3
(Date:5/20/2013)... Enrollment of patients with Type 2 diabetes ... trial of product candidate NewMet ™, a delayed-release ... 2 diabetes. Elcelyx expects to complete enrollment of 240 ... of the trial,s primary endpoint of change in fasting ... read-out for long-term glucose lowering and weight benefits is ...
(Date:5/20/2013)...  Medicare Part D seniors in plans with ... costs, convenient access to pharmacies and other benefits, ... Associates released today by the Pharmaceutical Care Management ... seniors (9.5 million) are currently enrolled in plans ... lower costs, pharmacy choices, and overall value of ...
(Date:5/19/2013)... , May 20, 2013 Claret Medical, Inc. ... Nicolas Van Mieghem et al., Histopathology ... Published ahead of print in Circulation, May 7 th ... Medical Center, Rotterdam, the Netherlands and ... of the Cardiovascular Pathology Institute, Gaithersburg, Maryland.  ...
Breaking Medicine Technology:Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2
Cached News: